Liang Wu

If you made any changes in Pure these will be visible here soon.

1,6- epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease
Kok, K., Kuo, C. L., Katzy, R. E., Lelieveld, L. T., Wu, L., Roig-Zamboni, V., Van Der Marel, G. A., Codée, J. D. C., Sulzenbacher, G., Davies, G. J., Overkleeft, H. S., Aerts, J. M. F. G. & Artola, M., 2 Aug 2022, In: Journal of the American Chemical Society. 144, p. 14819–14827 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Cryo-EM structures of human fucosidase FucA1 reveal insight into substate recognition and catalysis
Armstrong, Z., Meek, R. W., Wu, L., Blaza, J. N. & Davies, G. J., 29 Jul 2022, (E-pub ahead of print) In: Structure. 30, 15 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Mechanism based heparanase inhibitors reduce cancer metastasis in vivo
Boer, C. D., Armstrong, Z., Lit, V. A. J., Barash, U., Ruijgrok, G., Boyango, I., Weitzenberg, M. M., Schröder, S. P., Sarris, A. J. C., Meeuwenoord, N. J., Bule, P., Kayal, Y., Ilan, N., Codée, J. D. C., Vlodavsky, I., Overkleeft, H. S., Davies, G. J. & Wu, L., 26 Jul 2022, In: Proceedings of the National Academy of Sciences of the United States of America. 119, 31, e2203167119.
Research output: Contribution to journal › Article › peer-review

Open Access
File

Collaborations and top research areas from the last five years